151 related articles for article (PubMed ID: 20735832)
1. Tumour suppressor function of MDA-7/IL-24 in human breast cancer.
Patani N; Douglas-Jones A; Mansel R; Jiang W; Mokbel K
Cancer Cell Int; 2010 Aug; 10():29. PubMed ID: 20735832
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer.
Patani N; Jiang WG; Mokbel K
Cancer Cell Int; 2011 Jul; 11(1):23. PubMed ID: 21767406
[TBL] [Abstract][Full Text] [Related]
3. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.
Salhab M; Patani N; Jiang W; Mokbel K
Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741
[TBL] [Abstract][Full Text] [Related]
4. The mRNA expression of SATB1 and SATB2 in human breast cancer.
Patani N; Jiang W; Mansel R; Newbold R; Mokbel K
Cancer Cell Int; 2009 Jul; 9():18. PubMed ID: 19642980
[TBL] [Abstract][Full Text] [Related]
5. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.
Patani N; Jiang W; Newbold R; Mokbel K
J Carcinog; 2010 Nov; 9():9. PubMed ID: 21139993
[TBL] [Abstract][Full Text] [Related]
7. Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.
Jiang WG; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE; Fodstad O
Int J Cancer; 2005 Dec; 117(5):730-7. PubMed ID: 15957166
[TBL] [Abstract][Full Text] [Related]
8. Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.
Sasi W; Jiang WG; Sharma A; Mokbel K
BMC Cancer; 2010 Apr; 10():178. PubMed ID: 20433750
[TBL] [Abstract][Full Text] [Related]
9. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
Jiang WG; Douglas-Jones AG; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
[TBL] [Abstract][Full Text] [Related]
11. Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.
Cheng S; Douglas-Jones A; Yang X; Mansel RE; Jiang WG
Cancer Genomics Proteomics; 2010; 7(2):67-73. PubMed ID: 20335520
[TBL] [Abstract][Full Text] [Related]
12. N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer.
Martin TA; Pereira G; Watkins G; Mansel RE; Jiang WG
Clin Exp Metastasis; 2008; 25(2):97-108. PubMed ID: 17985201
[TBL] [Abstract][Full Text] [Related]
13. High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer.
Jin Q; Liu G; Wang B; Li S; Ni K; Wang C; Ren J; Zhang S; Dai Y
J Clin Pathol; 2020 Dec; 73(12):803-812. PubMed ID: 32404475
[TBL] [Abstract][Full Text] [Related]
14. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer.
Lane J; Martin TA; Watkins G; Mansel RE; Jiang WG
Int J Oncol; 2008 Sep; 33(3):585-93. PubMed ID: 18695890
[TBL] [Abstract][Full Text] [Related]
15. mRNA expression of DOK1-6 in human breast cancer.
Ghanem T; Bracken J; Kasem A; Jiang WG; Mokbel K
World J Clin Oncol; 2014 May; 5(2):156-63. PubMed ID: 24829863
[TBL] [Abstract][Full Text] [Related]
16. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.
Patani N; Jiang WG; Newbold RF; Mokbel K
Anticancer Res; 2011 Dec; 31(12):4115-25. PubMed ID: 22199269
[TBL] [Abstract][Full Text] [Related]
17. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.
Zheng M; Zhou Y; Yang X; Tang J; Wei D; Zhang Y; Jiang JL; Chen ZN; Zhu P
Breast Cancer Res Treat; 2014 Nov; 148(2):423-36. PubMed ID: 25348432
[TBL] [Abstract][Full Text] [Related]
18. Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levels.
De Blasio A; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Tesoriere G; Scerri C; Vento R; Di Fiore R
J Cell Physiol; 2019 Aug; 234(10):18432-18447. PubMed ID: 30912136
[TBL] [Abstract][Full Text] [Related]
19. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
20. Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth.
Li M; Xiao D; Zhang J; Qu H; Yang Y; Yan Y; Liu X; Wang J; Liu L; Wang J; Duan X
Oncol Rep; 2016 Dec; 36(6):3479-3487. PubMed ID: 27805252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]